Latest Revenue Growth News

Page 12 of 256
Artrya has fully integrated its Salix platform at Tanner Health, is preparing two more US sites for launch, and is finalising FDA submission for its Coronary Flow module, backed by a strong cash position of $76.6 million.
Ada Torres
Ada Torres
30 Apr 2026
Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.
Ada Torres
Ada Torres
30 Apr 2026
Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.
Ada Torres
Ada Torres
30 Apr 2026
Renowned boosts its US footprint with a landmark RE/MAX partnership and expands multi-year brokerage deals in Australia and New Zealand, driving 3% group revenue growth and positive cash flow in Q3 FY26.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.
Victor Sage
Victor Sage
30 Apr 2026
One Click Group delivered a remarkable 1000% increase in new users and a 64% reduction in acquisition costs in Q1 2026, setting the stage for strong revenue growth ahead of tax season.
Victor Sage
Victor Sage
30 Apr 2026
Osteopore Limited posted a 10% quarter-on-quarter revenue increase to AUD 754K in Q1 CY26, driven by new distribution deals across China, Latin America, and Hong Kong, alongside launching 3D printing services and securing innovative bone graft technologies in Asia Pacific.
Ada Torres
Ada Torres
30 Apr 2026
Appen Limited’s Q1 FY26 revenue rose 9% year-on-year to $54.8 million, driven by an 88% surge in its China business. Despite a 37% drop in the Global segment due to seasonality, the company reaffirmed full-year guidance and highlighted expanding AI operational efficiencies.
Sophie Babbage
Sophie Babbage
30 Apr 2026
ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.
Ada Torres
Ada Torres
30 Apr 2026
Dubber Corporation reported a historic positive underlying operating cashflow run-rate in Q3 FY26, driven by a USD 3.06 million initial payment from a Tier 1 North American communications service provider and ongoing cost reductions. Recurring revenue dipped 6% quarter-on-quarter due to portfolio optimisation and foreign exchange impacts.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Vection Technologies has reported its third straight quarter of positive operating cash flow, driven by a $30 million Defence order book and a surge in AI contracts worth $4 million across multiple sectors.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.
Victor Sage
Victor Sage
29 Apr 2026